{
    "title": "CureVac, GSK's experimental COVID variant vaccine effective in mice -study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10739501/CureVac-GSKs-experimental-COVID-variant-vaccine-effective-mice-study.html",
    "date": "2022-04-21",
    "keywords": [
        "vaccine",
        "bivalent",
        "covid19",
        "monovalent",
        "mrna",
        "curevac",
        "burger",
        "candidate",
        "development",
        "work",
        "beta",
        "coronavirus",
        "shot",
        "variant",
        "biontechpfizer",
        "moderna",
        "secondgeneration",
        "study",
        "mice",
        "antibody",
        "exposure",
        "delta",
        "load",
        "statement",
        "thursday",
        "point",
        "protection",
        "validation",
        "technology",
        "partnership",
        "covid",
        "market",
        "year",
        "partner",
        "glaxosmithkline",
        "biotech",
        "attempt",
        "show",
        "confidence",
        "month",
        "contract",
        "gsk",
        "case",
        "health",
        "testing",
        "omicron",
        "end",
        "march",
        "httpswwwcurevaccomencurevacandgskstartclinicaldevelopmentofsecondgenerationcovid19vaccinecandidatecv2cov",
        "china",
        "reporting",
        "kirsti",
        "knolle",
        "fenton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}